|
|
| Maladies Digestives > Etude de marché sectorielle |
| Partneringreview 2006 Vol 2 Ch 8: Gastrointestinal (PR06V2C08) |
|
|
|
|
€ 795,00 |
Editeur
: |
Bridgehead |
Langue
: |
Anglais |
Date de publication : |
Février 2006 |
Taille du document : |
66 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
U.S. Gastrointestinal Pharmaceuticals Prescription Drug Market, 2004-2011
1 pages | Mars 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
OTC Digestive Remedies in France
10 pages | Juin 2004 |
· OTC Digestive Remedies: Market SizeThe French market for digestive remedies declined by 1% on the previous year, reaching €295 million (US$333 million) in 2003.
· OTC D |
198,00 €
|
| |
| |
Diabetes Diagnostics
403 pages | Octobre 2005 |
This report analyzes the worldwide markets for Diabetes Diagnostics in Thousands of US$.
The major product segments analyzed are Blood Glucose Testing Devices, and Diabetes Testing Supplies.
The |
2 308,00 €
|
| |
| |
Stakeholder Insight: Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged
259 pages | Décembre 2004 |
IntroductionPancreatic adenocarcinoma is the fifth leading cancer-related cause of death and is thus a major health issue in the developed world.
Its aggressive nature and resistance to conventiona |
12 160,00 €
|
| |
| |
The Global Diabetes Market: Therapeutics, Diagnostics and Complications
218 pages | Août 2006 |
Diabetes is one of the largest therapeutic segments of global pharmaceutical sales and during the last 10 years it has grown by a compound average growth rate of nearly 20% from around US$4 billion in |
1 999,20 €
|
| |
| |
Healthy Eating - Spain
83 pages | Août 2006 |
About this reportThis report examines eating habits in terms of the level to which consumers are choosing healthy eating options, such as sugar-free, low-fat, functional and fortified products, as wel |
535,00 €
|
| |
| |
Decubitus Ulcer Treatment Products
281 pages | Octobre 2005 |
This report analyzes the worldwide markets for Decubitus Ulcer Treatment Products in Millions of US$.
The specific product segments analyzed are Air Fluidized Bed, Low Air Loss Beds, Air Wave Mattr |
2 308,00 €
|
| |
| |
Peptic Ulcers Testing
253 pages | Juillet 2005 |
This report analyzes the worldwide markets for Peptic Ulcers Testing in Millions of US$.
The specific product segments analyzed are Peptic Ulcer Testing.
The report provides separate comprehensi |
1 917,00 €
|
| |
| |
Top 10 Products Antiulcerant Market
1 pages | Septembre 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
US State Market Index: Drugs affecting neoplasms and endrocrine systems
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Drugs affecting neoplasms and endrocrine systems [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applie |
475,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Partneringreview 2006 Vol 2 Ch 8: Gastrointestinal (PR06V2C08) |
|
|
Partneringreview 2006 – Therapy area Gastrointestinal provides an in depth view into the gastrointestinal disease focused deals and alliances announced in 2005, in a clear and accessible format.
The report analyzes deals announced by company, industry focus, and development stage. Every deal is fully categorized, includes a detailed description mentioning the gastrointestinal disease being treated, and includes financials such as headline value, upfront and milestone payments, where disclosed.
Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report.
When using the PDF format in Acrobat Reader, simply click on the number to move around the report.
|
|
Introduction
About Partneringreview
Full contents of Partneringreview 2006
Review of deal making in 2005
Deals by therapy area
Chapter 8: Gastrointestinal
Deals in the gastrointestinal therapy area by company
Deals in the gastrointestinal therapy area by industry focus
Deals in the gastrointestinal therapy area by development stage
Chapter 15: List of deals
Glossary
Tables
Table 8 Top gastrointestinal area dealmaking companies in 2005
Figures
Fig. i.1 Deals announced by therapy focus
Fig. 8.1 Announcements in the gastrointestinal therapy area by company
Fig. 8.2 Announcements in the gastrointestinal therapy area by industry sector
Fig. 8.3 Announcements in the gastrointestinal therapy area by development stage
|
|
|
PPLSEN
|
|
|
|
|
